Latest ArticlesAnimal skins, one kind of necessary study materials, play an important role in the development of transdermal products. The barrier characteristics of skins should be considered. The 3H2O in vitro transdermal permeability and transepidermal water loss(TEWL) are effective methods and important indicators for evaluating the barrier function of skins. The results showed that the freshness, thickness, mass and steady-state TEWL were the critical quality control points of the skin model, which could further improve the reliability and accuracy of the research results. In addition, the in vitro transdermal permeability tests of total eight model drugs from seven brand-name drugs were carried out to evaluate the correlation of the permeability rate in common animal skin models(nude mouse and mini pig skins) and the drug release rate in clinical practice. This study provided a scientific basis in selecting skin model and its results indicated that pig skin, under strict quality control, was preferred to be used in predicting the pharmacokinetics profiles of transdermal products.
Compared with oral and injectable formulations, it is much more complicated in semisolid and suspension formulations for topical usage from the technical points of view. Due to the characteristics of multiple phases, irregular drug release kinetics and degradation thermodynamics, and generally without systemic absorption, the formulation development and characterization of topical semisolid drug products are facing challenges. Referring to the relevant technical guidelines issued by FDA, EMA and Center for Drug Evaluation of China as well as literature, this paper analyzes the key technical points on topical dermatologic drugs for Q3 equivalence study, including the critical quality attributes, in vitro release test(IVRT) and in vitro permeation test(IVPT), hoping to provide some references for in vitro consistency of generic drugs.
Rheological properties of semisolid preparations for topical skin use depend on the microstructures. Rheological behaviors may affect the manufacturing, appearance, stability, skin sensory properties, and in vivo performance of the semisolid preparations. The microstructure features of topical semisolid preparations can be characterized by rheological evaluation, which has a high application value in formulation development. The rheological parameters can serve as critical quality attributes of semisolid preparations for topical skin use, and can be used to predict storage stability and patient compliance. The general methods used for rheological evaluation are introduced and their applications in terms of formulation development, improvement in stability and patient compliance are reviewed in this paper.
Transdermal drug delivery system shows unique clinical advantages as well as commercial value in the development of improved new drugs. This review analyzes the characteristics of transdermal patches approved by FDA in recent years from the perspectives of improving patient compliance and drug safety, and introduces the non-clinical and clinical assessment requirements of improved transdermal patches. It is expected to provide some references for the development of improved transdermal products. Meanwhile, the critical aspects in the development process of transdermal patches are also introduced.
Transdermal tulobuterol patch, which contains a β2-adrenergic receptor-specific agonist, is the first long-acting bronchodilator that can be used as a transdermal patch. This paper traces the prescription and technology of the original patches and combs the research progress at home and abroad to provide ideas for the development of domestic generic tulobuterol patches.
Transdermal drug delivery is an important drug delivery route for treating skin-related diseases, which has both advantages and limitations. The development and application of new carriers such as multi-microbubble dispersion and microsponges can improve stability and drug loading of different active ingredients in compound preparations for transdermal administration. The new adhesives can make patches enduringly adhere to the skin surface to realize continuous drug delivery. In this review, the dermatological preparations approved by FDA are selected, and the new carrier technologies are introduced, which might provide a reference for future research on topical and transdermal formulations.
Featured by self-administration, painless and minimally invasive surgery, direct drug delivery to the nidus, and controllable drug release, the microneedle technique enjoys a unique application prospect in treating dermatoses. Hence, it has become a research hotspot in dermatologic therapy and shows obvious therapeutic advantages. This review focuses on introducing the progress of researches at home and abroad on the treatment of hyperpigmentation, cicatrix, psoriasis, skin injury and tinea by microneedles, and further elaborates the perspectives of medicines, microneedle materials, and evaluations on therapeutic effects to provide a reference for skin disease treatment research.
At present, the oral modified-release preparations of bupropion hydrochloride have been widely used in antidepressant treatment, and the development of their generic drugs has also become one of the hot spots. There are great differences in the formulation process and quality control of different modified-release preparations. Based on analysis of relevant literature and the dossiers, some key points of the formulation process and quality control of oral bupropion hydrochloride modified-release preparations are discussed, and some general considerations about pharmaceutical studies are put forward, in order to provide certain references for the R&D of generic drugs. It's recommended to take clinical needs into account and conduct further in-depth pharmaceutical studies in combination with characteristics of drug substances and excipients as well as drug release mechanisms to ensure the consistency in quality and efficacy between the generic and reference drugs.
As a covering material for wounds, medical dressings can stop bleeding during the healing process, and can also act as a physical barrier against external microorganisms to reduce the probability of wound infection. With the development of science, medical dressings gradually trend to be functional and diversified. Collagen has the advantages of low immunogenicity, excellent biocompatibility and biodegradation, and it is used as a biological material in pharmaceutical and medical fields. Composite collagen-based dressings prepared with collagen as raw material and active ingredients have been gradually applied to superficial skin wounds and scalds, scar repair, antibacterial products for women, and repair after medical cosmetic surgery. This paper introduces the biological properties of collagen and the research progress of collagen-based medical dressings, which may provide a theoretical basis and new ideas for the research and development of medical dressings.